Oral	JJ	_
polio	NN	_
vaccines	NNS	_
were	VBD	_
developed	VBN	_
by	IN	_
several	JJ	_
groups	NNS	_
,	,	_
one	CD	_
of	IN	_
which	WDT	_
was	VBD	_
led	VBN	_
by	IN	_
Albert	NNP	_
Sabin	NNP	_
.	.	_

Other	JJ	_
groups	NNS	_
,	,	_
led	VBN	_
by	IN	_
Hilary	NNP	_
Koprowski	NNP	_
and	CC	_
H.R.	NNP	_
Cox	NNP	_
,	,	_
developed	VBD	_
their	PRP$	_
own	JJ	_
attenuated	JJ	_
vaccine	NN	_
strains	NNS	_
.	.	_

The	DT	_
various	JJ	_
vaccines	NNS	_
were	VBD	_
carefully	RB	_
evaluated	VBN	_
for	IN	_
their	PRP$	_
ability	NN	_
to	TO	_
induce	VB	_
immunity	NN	_
to	IN	_
polio	NN	_
,	,	_
while	IN	_
retaining	VBG	_
a	DT	_
low	JJ	_
incidence	NN	_
of	IN	_
neuropathogenicity	NN	_
in	IN	_
monkeys	NNS	_
.	.	_

Based	VBN	_
on	IN	_
these	DT	_
results	NNS	_
,	,	_
the	DT	_
Sabin	NNP	_
strains	NNS	_
were	VBD	_
chosen	VBN	_
for	IN	_
worldwide	JJ	_
distribution	NN	_
.	.	_

